Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...

A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

McDonald's is suing major meatpackers for allegedly colluding to inflate beef prices by limiting supplies since 2015. PepsiCo ...

On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...

Even though there is no official Ozempic Diet, there are certain foods you can avoid to minimize your chances of negative ...

FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...

Explore updated guidelines for diagnosing and treating metabolic dysfunction-associated steatotic liver disease ...

A trade group representing large compounding pharmacies sued the FDA over its removal of a widely prescribed Lilly diabetes ...

While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.

When a drug is on FDA’s drug shortage list, outsourcing facilities by law may help address the drug shortage by producing an “essential copy” version of the shortage drug using bulk drug substances.

All doses of the diabetes and weight management injectable tirzepatide (Mounjaro, Zepbound) were taken off the FDA's shortage ...